[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569438":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":7,"locations":18,"responsibleParty":32,"collaborators":36,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":7,"eligibilityCriteria":46,"healthyVolunteers":42,"sex":47,"minAge":7,"maxAge":7,"enrollmentInfo":48,"targetDuration":51,"studyType":52,"phases":7,"briefSummary":53,"conditions":54,"keywords":58,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Cairo University","OTHER",null,[9,12,15],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"Improving technique","A checklist was developed to ensure the important steps were followed, with tips for obtaining a more adequate sample. This checklist was put in the outpatient procedures room, and each physician performing a biopsy was asked to fill it out.\n\nAlso, a diagram containing illustrative images with the basic steps was put in the procedures room.\n\nThe topic was covered in the biweekly scientific meeting, and all factors attributed to the inadequate sample were discussed.\n\nThe department lead mentioned the topic in the OBGYN department's private messaging group.\n\nIt was finally mentioned in the morning meeting.",{"type":6,"name":13,"description":14,"armGroupLabels":7,"otherNames":7},"Using hysteroscopy in candidate patients","Patients with focal lesions on ultrasound will undergo hysteroscopy and biopsy instead of blind endometrial sampling.\n\nPatient with stenosed cervix or failed previous sampling might also undergo hysteroscopic guided biopsy.",{"type":6,"name":16,"description":17,"armGroupLabels":7,"otherNames":7},"Analgesia","Analgesia in the form of paracetamol or NSAIDs might be given to some patients 30- 60 minutes before the procedure to reduce the procedure-associated pain and the resultant failure to complete it and obtain an adequate sample.",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":22,"countryCode":25,"cosmosGeoPoint":7,"geoPoint":7,"contacts":26},"Adan hospital","RECRUITING","Kuwait","Al Ahmadi","47000","KW",[27],{"name":28,"role":29,"phone":30,"phoneExt":7,"email":31},"Tarek","CONTACT","+965-99780408","tarekelkhatib1952@gmail.com",{"type":33,"investigatorFullName":34,"investigatorTitle":35,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Islam Tarek Elkhateb","Dr",[37],{"name":38,"class":39},"Al Adan Hospital Kuwait","INDUSTRY","100569438","improving-outpatient-endometrial-biopsy-results-100569438",false,"NCT06694246","Improving Outpatient Endometrial Biopsy Results","Outpatient Endometrial Biopsy Results; a Quality Improvement Project.","Inclusion Criteria:\n\n* All patients undergoing outpatient endometrial biopsy in the specified time interval (11\u002F2024- 4\u002F2025) will be included.\n\nExclusion Criteria:\n\n* Could not obtain the sample due to patient physicals, anxiety (patient decline), cervical stenosis, or severe bleeding","FEMALE",{"count":49,"type":50},400,"ESTIMATED","6 Months","OBSERVATIONAL","Pipelle is the most commonly used outpatient endometrial biopsy device. Pipelle endometrial biopsy can diagnose 90% of endometrial cancer cases. Pipelle endometrial biopsy is one of the first-line diagnostic procedures for women presenting with abnormal peri- and post-menopausal vaginal bleeding.\n\nInsufficient samples are obtained in 5-23% of cases. In Adan Hospital, a retrospective analysis of all outpatient endometrial samples sent to the histopathology department from April- to October 2024 study showed an insufficient sample percentage of 32% This may be attributed to factors such as patients, equipment, and physicians.\n\nThis project aims to improve the endometrial biopsy results by Identifying these factors in the Adan hospital setting, Implementing measures to modify these factors, and finally re-auditing the endometrial biopsy results after six months.",[55,56,57],"Histopathology","Screening Tool","Techniques",[59,60,61,62,63,64],"Pipelle","Endometrial biopsy","histopathology","endometrial sampling","screening","outpatient","2024-12-02",{"date":67,"type":68},"2024-12-04","ACTUAL",{"date":70,"type":68},"2024-11-01",{"date":72,"type":50},"2025-04-30",{"name":5,"class":6},1]